Basit öğe kaydını göster

Go-Beyond: A Real-World Persistence Study With Golimumab In Patients With Axial Spondyloarthritis And Rheumatoid Arthritis In Turkey

dc.contributor.authorAkar, Servet
dc.contributor.authorKalyoncu, Umut
dc.contributor.authorDalkili, Ediz
dc.contributor.authorEmmungil, Hakan
dc.date.accessioned2021-06-03T05:20:05Z
dc.date.available2021-06-03T05:20:05Z
dc.date.issued2019
dc.identifier.issn0003-4967
dc.identifier.urihttp://dx.doi.org/10.1136/annrheumdis-2019-eular.5674
dc.identifier.urihttp://hdl.handle.net/11655/23978
dc.language.isoen
dc.relation.isversionof10.1136/annrheumdis-2019-eular.5674
dc.rightsAttribution 4.0 United States
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleGo-Beyond: A Real-World Persistence Study With Golimumab In Patients With Axial Spondyloarthritis And Rheumatoid Arthritis In Turkey
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalAnnals Of The Rheumatic Diseases
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume78
dc.identifier.issue2
dc.description.indexWoS


Bu öğenin dosyaları:

Ad:
395.pdf
Boyut:
372.9Kb
Biçim:
PDF
Göster/Aç

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

Attribution 4.0 United States
Aksi belirtilmediği sürece bu öğenin lisansı: Attribution 4.0 United States